• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years?

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Evans, D. G.
    Howell, Sacha J
    Burghel, G. J.
    Forde, C.
    Lalloo, F.
    Smith, M. J.
    Howell, A.
    Gandhi, A.
    Woodward, E. R.
    Affiliation
    The Christie NHS Foundation Trust, Manchester, UK
    Issue Date
    2024
    
    Metadata
    Show full item record
    Citation
    Evans DG, Howell SJ, Burghel GJ, Forde C, Lalloo F, Smith MJ, et al. Germline testing for breast cancer patients in England: illogical to prioritise grade 1 breast cancer aged 30-39 over grade 3 aged 40-49 years? Journal of medical genetics. 2024 2024 JUL 25. PubMed PMID: WOS:001279890700001. English.
    Journal
    Journal of Medical Genetics
    URI
    http://hdl.handle.net/10541/627137
    PubMed ID
    39054051
    Language
    en
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany.
    • Authors: Hamann U, Liu X, Lange S, Ulmer HU, Benner A, Scott RJ
    • Issue date: 2002 Mar
    • Evidence Grows for Universal Germline Genetic Testing for Patients with Breast Cancer.
    • Issue date: 2023 Feb
    • Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
    • Authors: Van Marcke C, Helaers R, De Leener A, Merhi A, Schoonjans CA, Ambroise J, Galant C, Delrée P, Rothé F, Bar I, Khoury E, Brouillard P, Canon JL, Vuylsteke P, Machiels JP, Berlière M, Limaye N, Vikkula M, Duhoux FP
    • Issue date: 2020 Apr 15
    • Results from London Regional Clinical Genetics services over a 5-year period on germline TP53 testing in women diagnosed with breast cancer at <30 years.
    • Authors: Garrett A, Talukdar S, Izatt L, Brady AF, Whyte S, Josephs KS, Shanmugasundaram M, Guillemot LS, Vakili D, Ey S, Ahmed M
    • Issue date: 2022 Jun
    • Germline BRCA1 and BRCA2 testing for breast cancer survivors.
    • Authors: Wiggins J, McLoughlin A, George A, Ring A, Kemp Z
    • Issue date: 2020 Aug
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.